Lower urinary tract symptom
Conditions
Interventions
Choreito treatment
Sponsors
Takei Mineo
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patient aged 20 to 90 Female patient with CLSS questionnaire Q9 (Bladder pain) 2 or higher Total IPSS score 8 or higher
Exclusion criteria
Exclusion criteria: Patient with serious cardiovascular, liver disease and renal dysfunction. Liver disease:Patients whose AST, ALT or both are more than three times the facility reference upper limit. Renal dysfunction:Creatinine are more than 2 times the facility reference upper limit. Woman who is pregnant, nursing, wishes to be come pregnant the study period, or can not follow instruction of physician regarding contraception. Patients who carried the radiation therapy to the pelvis. Patients with activity of urinary tract infection. Patients who have history of Kampo allergies. Other patients who are assessed to be inappropriate for study participation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Core Lower Urinary Tract Symptom Score(CLSS) Q9 (Bladder pain) | — |
Secondary
| Measure | Time frame |
|---|---|
| CLSS IPSS IPSS-QOL Severity criteria for interstitial cystitis Uroflowmetry Residual urine Record of urination Overall Treatment Efficacy Blood parameter (IFNg, High sensitive CRP) | — |
Contacts
Public ContactFusami Shibata
Harasanshin Hospital
Outcome results
None listed